Imaging Follow-up After Stone Treatment
Imaging Follow-up of Patients With Urinary Stones: Ultrasound-Based Randomized Controlled Trial
Kidney stones are a common condition that can recur even after successful treatment. Regular imaging tests can help detect new stones, but frequent use of X-rays and CT scans can expose patients to unnecessary radiation. It is not yet clear how often patients should have imaging tests after treatment.
This study compares two schedules for monitoring patients who have undergone treatment for kidney stones and have no significant remaining stones. Participants are randomly assigned to one of two groups. One group has an ultrasound examination of the kidneys and urinary tract every 6 months, while the other group has the same examination every 12 months.
The study aims to determine whether more frequent ultrasound examinations can reduce unexpected episodes related to kidney stones, such as pain, bleeding in the urine, or urinary infections caused by blocked urine flow.
The researchers will also assess changes in kidney function, visits to the emergency department, the number of imaging tests performed, the development or growth of stones without symptoms, and the overall cost of imaging.
The study includes adults with a low or high risk of kidney stones recurrence and is conducted at Sismanoglio General Hospital in Athens, Greece.
The findings may help determine an appropriate schedule for monitoring patients after kidney stone treatment while reducing unnecessary tests, radiation exposure, and healthcare costs.
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Studietype
Studietype
Registrering (Antatt)
Registrering
Fase
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
Studiekontakt
- Navn: Lazaros Tzelves
- Telefonnummer: 00306944104974
- E-post: lazarostzelves@gmail.com
Studer Kontakt Backup
- Navn: Panagiotis Neofytou
- Telefonnummer: 00306996288898
- E-post: neo.panagiotis@gmail.com
Studiesteder
-
-
Attica
-
Athens, Attica, Hellas, 15126
- 2nd Department of Urology, Sismanoglio General Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Adults aged 18 years or older, including both males and females.
- Patients with urolithiasis of any stone composition.
- Patients with stones at any anatomical location.
- Patients undergoing any definitive stone treatment procedure, including extracorporeal shock wave lithotripsy (SWL), ureteroscopy (URS), retrograde intrarenal surgery (RIRS), or percutaneous nephrolithotomy (PCNL).
- Patients classified as either low-risk or high-risk for stone recurrence according to European Association of Urology (EAU) criteria.
- Patients with no significant residual stone fragments following treatment, defined as the absence of residual fragments larger than 2 mm at 4-6 weeks after the procedure, assessed by radiography and ultrasound or low-dose computed tomography.
Exclusion Criteria:
- Refusal to participate in the study.
- Patients with anatomical abnormalities or a history of previous open surgery for stone disease.
- Patients with a solitary kidney or chronic kidney disease.
- Patients with occupations considered to be associated with a high risk of stone disease, such as pilots.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Antall våpen
Våpen og intervensjoner
Deltakergruppe / ArmDeltakergruppe / Arm |
Intervensjon / BehandlingIntervensjon / Behandling |
|---|---|
|
Aktiv komparator: 6-monthly ultrasound follow-up
|
kidney, ureter, bladder ultrasound every 6 months kidney, ureter, bladder ultrasound every 12 months |
|
Aktiv komparator: 12-monthly ultrasound follow-up
|
kidney, ureter, bladder ultrasound every 6 months kidney, ureter, bladder ultrasound every 12 months |
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Incidence of Symptomatic Stone Episodes
Tidsramme: from randomization until the end of follow-up period, 1 year after intervention
|
Occurrence of symptomatic stone episodes during a one-year follow-up period, defined as any of the following: a new episode of renal colic or pain, hematuria not attributable to another cause, or urinary tract infection associated with obstruction caused by a newly formed stone. In patients with no visible residual stone fragments after treatment, the detection of any stone during follow-up will be considered recurrence. In patients with residual fragments smaller than 2 mm, detection of any fragment measuring 3 mm or larger will be considered recurrence. |
from randomization until the end of follow-up period, 1 year after intervention
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Estimated Glomerular Filtration Rate (eGFR)
Tidsramme: from randomization until the end of follow-up period, 1 year after intervention
|
Change in estimated glomerular filtration rate (eGFR) during the follow-up period, as an indicator of changes in kidney function. |
from randomization until the end of follow-up period, 1 year after intervention
|
|
Number of Emergency Department Visits
Tidsramme: from randomization until the end of follow-up period, 1 year after intervention
|
Number of visits to the emergency department during the follow-up period. |
from randomization until the end of follow-up period, 1 year after intervention
|
|
Number of Imaging Examinations Performed
Tidsramme: from randomization until the end of follow-up period, 1 year after intervention
|
Total number of imaging examinations performed during the follow-up period for the evaluation of urolithiasis, including plain radiographs, computed tomography scans, and ultrasound examinations. |
from randomization until the end of follow-up period, 1 year after intervention
|
|
Incidence of Asymptomatic Stone Growth
Tidsramme: from randomization until the end of follow-up period, 1 year after intervention
|
Number of patients who develop asymptomatic stone growth during the follow-up period, as detected by imaging examinations. |
from randomization until the end of follow-up period, 1 year after intervention
|
|
Total Cost of Imaging Examinations
Tidsramme: from randomization until the end of follow-up period, 1 year after intervention
|
Total cost of imaging examinations performed during the follow-up period for the evaluation and monitoring of urolithiasis. |
from randomization until the end of follow-up period, 1 year after intervention
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Samarbeidspartnere
Samarbeidspartnere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Studiestart
Primær fullføring (Antatt)
Primær fullføring
Studiet fullført (Antatt)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
Andre studie-ID-numre
- 5949/21.01.2025
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .